|
|
||||||||
1 Departments of Surgery, Medicine, and Cell Biology, Connecticut Health Care Department of Veterans Affairs, West Haven, and Yale University School of Medicine, New Haven, Connecticut 06516; 2 Department of Visceral and Transplantation Surgery, University of Bern, 3010 Bern, Switzerland; and 3 AlphaGene, Inc., Charlestown, Massachusetts 02129
To identify the
muscarinic subtype present on the rat pancreatic acinar cell, we
examined the effects of different muscarinic receptor antagonists on
amylase secretion and proteolytic zymogen processing in isolated rat
pancreatic acini. Maximal zymogen processing required a concentration
of carbachol 10- to 100-fold greater (10
3 M) than that required
for maximal amylase secretion
(10
5 M). Although both
secretion and conversion were inhibited by the M3 antagonist
4-diphenylacetoxy-N-methyl-piperidine
(4-DAMP) (50% inhibition ~6 × 10
7 M and 1 × 10
8 M, respectively), the
most potent inhibitor was the M1 antagonist telenzepine (50%
inhibition ~5 × 10
10 M and 1 × 10
11 M, respectively).
Pirenzepine, another M1 antagonist, and the M2 antagonist methoctramine
did not reduce amylase secretion or zymogen processing in
concentrations up to 1 × 10
5 M. Analysis of acinar
cell muscarinic receptor by PCR revealed expression of both m1 and m3
subtypes. The pancreatic acinar cell has a distinct
pattern of muscarinic antagonist sensitivity (telenzepine
4-DAMP > pirenzepine) with respect to both amylase secretion and zymogen
conversion.
muscarinic antagonist; 4-diphenylacetoxy-N-methyl-piperidine; carboxypeptidase A1; secretion
This article has been cited by other articles:
![]() |
A. Chaudhuri, S. Z. Husain, T. R. Kolodecik, W. M. Grant, and F. S. Gorelick Cyclic AMP-dependent protein kinase and Epac mediate cyclic AMP responses in pancreatic acini Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1403 - G1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Xie, C. Drachenberg, M. Yamada, J. Wess, and J.-P. Raufman Cholinergic agonist-induced pepsinogen secretion from murine gastric chief cells is mediated by M1 and M3 muscarinic receptors Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G521 - G529. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chaudhuri, T. R. Kolodecik, and F. S. Gorelick Effects of increased intracellular cAMP on carbachol-stimulated zymogen activation, secretion, and injury in the pancreatic acinar cell Am J Physiol Gastrointest Liver Physiol, February 1, 2005; 288(2): G235 - G243. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Niebergall-Roth, S. Teyssen, and M. V. Singer Effects of M1 and CCK antagonists on latency of pancreatic amylase response to intestinal stimulants Am J Physiol Gastrointest Liver Physiol, August 1, 2000; 279(2): G411 - G416. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |